Infant Respiratory Interface and Accessories Evaluation Study
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Michelle Muir
- Phone Number: 095740100
- Email: michelle.muir@fphcare.co.nz
Study Locations
-
-
Queensland
-
Brisbane, Queensland, Australia, 4101
- Mater Mothers' Hospital NICU
-
Principal Investigator:
- Luke Jardine
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Spontaneously breathing infants who require non-invasive respiratory support
- Parent(s)/guardian(s) at least 18 years of age
Exclusion Criteria:
- Parent(s)/guardian(s) unable to give written informed consent
- Neonate or infant not requiring non-invasive support
- Suspected or confirmed abnormalities or trauma to the skull or airway
Study Plan
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
EXPERIMENTAL: Respiratory interface
Use of the new respiratory interface and accessories to deliver non-invasive therapy
|
Application of the new interface and accessories and provision of non-invasive respiratory support through the device.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Feedback score
Time Frame: 12 hours
|
12 hours
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Study Start
Primary Completion (ANTICIPATED)
Primary Completion
Study Completion (ANTICIPATED)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ACTUAL)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- UT-1111-1267-0940
- CIA-235 (OTHER: Fisher & Paykel Healthcare)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.